Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prostate cancer. Treatment].

G Fournier1, A Valeri, P Mangin

  • 1Service d'urologie, Centre hospitalier universitaire de Brest, hôpital de la Cavale Blanche, boulevard Tanguy-Prigent, 29609 Brest, France. georges.fournier@chu-brest.fr

Annales D'Urologie
|December 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I Clinical Study of DOC1021 (dubodencel) for Adjuvant Immunotherapy of Glioblastoma.

medRxiv : the preprint server for health sciences·2026
Same author

Volumetric variations in the buccal fat pad, parapharyngeal adipose corpus, and orbital fat according to sex, age, and body mass index: an MRI study with segmentation.

International journal of oral and maxillofacial surgery·2025
Same author

Rational optimization of D3R/GSK-3β dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studies.

European journal of medicinal chemistry·2025
Same author

Which protocol for prostate biopsies in patients with a positive MRI? Interest of systematic biopsies by sectors.

Prostate cancer and prostatic diseases·2023
Same author

Impact of age on the Quadrella index assessing oncological and functional results after prostate brachytherapy: A 6-year analysis.

Journal of contemporary brachytherapy·2023
Same author

Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy.

World journal of urology·2023
Same journal

Prostate cancer at the 2007 ASCO meeting: an urologist's perspective.

Annales d'urologie·2008
Same journal

[Surgical treatment of ureteropyelic junction stenosis using robotic-assisted laparoscopy].

Annales d'urologie·2008
Same journal

[Robotic-assisted laparoscopy: general principles].

Annales d'urologie·2008
Same journal

[De novo tumours of renal transplants].

Annales d'urologie·2008
Same journal

[Immunosuppression in kidney transplantation].

Annales d'urologie·2008
Same journal

[Surgical complications in kidney transplantation].

Annales d'urologie·2008
See all related articles

Early diagnosis of prostate cancer using prostate-specific antigen (PSA) has improved management. While hormone therapy is effective, hormone resistance remains a challenge, necessitating further research for improved prostate cancer survival.

Area of Science:

  • Urology
  • Oncology
  • Biochemistry

Context:

  • Prostate cancer management has been significantly advanced by the discovery and utilization of prostate-specific antigen (PSA) for early diagnosis.
  • Historically, prostate cancer was often detected at advanced, incurable stages, primarily affecting older men.

Purpose:

  • To review the evolution of prostate cancer management, highlighting the impact of PSA, advances in treatment modalities, and the role of hormone therapy.
  • To discuss the current strategies for localized and advanced prostate cancer, including curative treatments, hormone therapy, and challenges like hormone resistance.

Summary:

  • The advent of PSA testing has transformed prostate cancer into a primarily curable disease when detected early and localized.
  • Treatment strategies have evolved with surgical and radio-therapeutic advancements, aiming to balance survival and quality of life.

Related Experiment Videos

  • Hormone therapy, a cornerstone for advanced prostate cancer, relies on androgen deprivation but faces the challenge of inevitable hormone resistance.

    • Impact:

    • Early detection through PSA screening remains the most effective method for reducing prostate cancer mortality.
    • Improved understanding of tumor heterogeneity allows for better risk stratification and personalized therapeutic strategies.
    • Despite advancements, the development of effective treatments for hormone-refractory prostate cancer and disease prevention requires further research.